Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 153,200 | 105,200 | 157,600 | 142,200 | 36,600 |
| Depreciation Amortization | 221,800 | 212,000 | 204,500 | 186,200 | 201,700 |
| Income taxes - deferred | -10,900 | 6,600 | -11,800 | 52,400 | 41,300 |
| Accounts receivable | -19,000 | -4,200 | -12,900 | -4,900 | -11,500 |
| Accounts payable and accrued liabilities | 63,100 | -200 | 2,000 | -22,900 | 12,100 |
| Other Working Capital | 35,500 | -42,900 | -5,000 | -68,300 | -15,900 |
| Other Operating Activity | -9,300 | 72,600 | 12,500 | 61,900 | 88,800 |
| Operating Cash Flow | $434,400 | $349,100 | $346,900 | $346,600 | $353,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -173,700 | -155,100 | -104,800 | -86,100 | -66,700 |
| Net Acquisitions | -9,600 | -4,000 | -200,600 | -97,200 | -37,000 |
| Sale Of Investment | 0 | 6,000 | 46,800 | 0 | 0 |
| Other Investing Activity | 0 | 2,700 | 0 | -100 | 2,600 |
| Investing Cash Flow | $-183,300 | $-150,400 | $-258,600 | $-183,400 | $-101,100 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 963,300 | N/A | N/A | N/A | 1,006,000 |
| Debt Issued | -23,300 | 745,300 | 476,300 | -20,600 | -998,900 |
| Debt Repayment | N/A | -428,000 | N/A | N/A | -74,700 |
| Common Stock Issued | N/A | 100 | 1,300 | 2,500 | 400 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,800 | -1,300 |
| Dividend Paid | -139,100 | -294,800 | -132,200 | -287,300 | -129,800 |
| Other Financing Activity | -979,500 | -355,100 | -262,300 | 500 | -6,000 |
| Financing Cash Flow | $-178,600 | $-332,500 | $83,100 | $-306,700 | $-204,300 |
| Beginning Cash Position | 147,100 | 280,900 | 109,500 | 253,000 | 205,300 |
| End Cash Position | 219,600 | 147,100 | 280,900 | 109,500 | 253,000 |
| Net Cash Flow | $72,500 | $-133,800 | $171,400 | $-143,500 | $47,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 434,400 | 349,100 | 346,900 | 346,600 | 353,100 |
| Capital Expenditure | -185,700 | -156,800 | -112,100 | -89,200 | -87,200 |
| Free Cash Flow | 248,700 | 192,300 | 234,800 | 257,400 | 265,900 |